fda-provides-eua-for-covid-19-treatment 
Dimensions of Dental Hygiene
NOVEMBER 10, 2020
On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The post FDA Provides EUA for COVID-19 Treatment appeared first on Dimensions of Dental Hygiene.
Denticle
JULY 22, 2021
The Food and Drug Administration (FDA) has stated that an Emergency Use Authorization (EUA) for a Covid-19 vaccine safe to administer to children under 12 may be available midwinter of 2021-2022. When the testing was being done for the 12 and over group the FDA only required 2 months of data.
Expert insights. Personalized for you.
98 
Let's personalize your content